A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

Clinical trial NCT03015129 · COMPLETED

Trial details

NCT number: NCT03015129
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Endometrial Carcinosarcoma Endometrial Carcinoma Endometrial Cancer Recurrent Endometrial Carcinoma, Recurrent

Start date: 2017-01-01
Primary completion: 2022-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.